retatrutide diabetes trial

retatrutide diabetes trial Delivers Significant Hemoglobin A1C Reduction, Weight Loss in Phase 3 Type 2 retatrutide phase 2 trial obesity

Name: retatrutide diabetes trial Delivers Significant Hemoglobin A1C Reduction, Weight Loss in Phase 3 Type 2 retatrutide phase 2 trial obesity
Brand: eric-jean.com
SKU: 26775619809
Price: 25.45 USD
Availability: InStock
Rating: 4.315 (22 reviews)

SKU: 26775619809

4.3

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 2 - Oct 7

Description

To view or add a comment, sign in Dr

Retatrutide is a first-in-class triple hormone receptor agonist whose Phase 3 data, released through late 2025 and 2026, has pushed Canadian research interest to record highs

Discuss with your doctor whether the potential additional 10-15% weight loss justifies new titration, higher discontinuation risk, and insurance challenges